Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 127006911 | 12700691 | 1 | I | 20160603 | 20160830 | 20160830 | PER | US-SA-2016SA107641 | AVENTIS | 90.00 | YR | E | F | Y | 0.00000 | 20160830 | CN | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 127006911 | 12700691 | 1 | PS | MULTAQ | DRONEDARONE | 1 | Unknown | EM025 | 22425 | 400 | MG | TABLET | BID | ||||||
| 127006911 | 12700691 | 2 | C | ATENOLOL. | ATENOLOL | 1 | 0 | ||||||||||||
| 127006911 | 12700691 | 3 | C | ATORVASTATIN | ATORVASTATIN | 1 | 1 TABLET 3XWEEK | 0 | 1 | DF | TABLET | ||||||||
| 127006911 | 12700691 | 4 | C | CARVEDILOL. | CARVEDILOL | 1 | 0 | 1 | DF | QD | |||||||||
| 127006911 | 12700691 | 5 | C | WARFARIN | WARFARIN | 1 | Oral | 3.5 BY MOUTH MON-THURSDAY AND REST OF THE WEEK 5.0 | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 127006911 | 12700691 | 1 | Prophylaxis |
| 127006911 | 12700691 | 2 | Atrial fibrillation |
Outcome of event
| no results found |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 127006911 | 12700691 | Amnesia | |
| 127006911 | 12700691 | Heart rate irregular | |
| 127006911 | 12700691 | Visual impairment |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| no results found |